This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Ayurcann Holdings (AYUR) Stock Overview

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. More details

AYUR fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Trading at 93.7% below our estimate of its fair value

Risk Analysis

Negative shareholders equity

Earnings have declined by 28% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap (CA$2M)

AYUR Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW485,942 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

485,942 investors already sharing narratives

View all narratives

Ayurcann Holdings Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ayurcann Holdings
Historical stock prices
Current Share Price	CA$0.01
52 Week High	CA$0.045
52 Week Low	CA$0.005
Beta	0.87
1 Month Change	0%
3 Month Change	0%
1 Year Change	-60.00%
3 Year Change	-81.82%
5 Year Change	-94.44%
Change since IPO	-97.80%

Recent updates

Analysis Article • Jun 28

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

The Ayurcann Holdings Corp. ( CSE:AYUR ) share price has done very well over the last month, posting an excellent gain...

Analysis Article • May 11

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

The Ayurcann Holdings Corp. ( CSE:AYUR ) share price has softened a substantial 33% over the previous 30 days, handing...

Analysis Article • Mar 22

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Ayurcann Holdings Corp. ( CSE:AYUR ) shares have had a horrible month, losing 29% after a relatively good period...

Shareholder Returns

	AYUR	CA Pharmaceuticals	CA Market
7D	0%	3.3%	0.7%
1Y	-60.0%	13.0%	30.5%

Return vs Industry: AYUR underperformed the Canadian Pharmaceuticals industry which returned 68.6% over the past year.

Return vs Market: AYUR underperformed the Canadian Market which returned 33.9% over the past year.

Price Volatility

Is AYUR's price volatile compared to industry and market?
AYUR volatility
AYUR Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	8.4%
Market Average Movement	9.5%
10% most volatile stocks in CA Market	16.3%
10% least volatile stocks in CA Market	3.7%

Stable Share Price: AYUR's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine AYUR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Igal Sudman	ayurcann.com

Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products.

Ayurcann Holdings Corp. Fundamentals Summary

How do Ayurcann Holdings's earnings and revenue compare to its market cap?
AYUR fundamental statistics
Market cap	CA$1.95m
Earnings (TTM)	-CA$4.34m
Revenue (TTM)	CA$31.28m

0.1x

P/S Ratio

-0.4x

P/E Ratio

Is AYUR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AYUR income statement (TTM)
Revenue	CA$31.28m
Cost of Revenue	CA$22.66m
Gross Profit	CA$8.62m
Other Expenses	CA$12.97m
Earnings	-CA$4.34m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.022
Gross Margin	27.57%
Net Profit Margin	-13.88%
Debt/Equity Ratio	-3.0%

How did AYUR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/06 05:26
End of Day Share Price	2026/03/09 00:00
Earnings	2025/09/30
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ayurcann Holdings Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Siddharth Rajeev	Fundamental Research Corp.

This company listing is no longer active

Ayurcann Holdings (AYUR) Stock Overview

Rewards

Risk Analysis

Join community and earn perks

Ayurcann Holdings Corp. Competitors

Silo Wellness

CanadaBis Capital

Delivra Health Brands

1933 Industries

Price History & Performance

Recent News & Updates

Emblem Cannabis Corporation completed the acquisition of Ayurcann Inc. from Ayurcann Holdings Corp. (CNSX:AYUR) for CAD 5.5 million.

First quarter 2026 earnings released: CA$0.006 loss per share (vs CA$0.002 loss in 1Q 2025)

Full year 2025 earnings released: CA$0.018 loss per share (vs CA$0.022 loss in FY 2024)

Insufficient new directors

Third quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 3Q 2024)

New major risk - Negative shareholders equity

Recent updates

Emblem Cannabis Corporation completed the acquisition of Ayurcann Inc. from Ayurcann Holdings Corp. (CNSX:AYUR) for CAD 5.5 million.

First quarter 2026 earnings released: CA$0.006 loss per share (vs CA$0.002 loss in 1Q 2025)

Full year 2025 earnings released: CA$0.018 loss per share (vs CA$0.022 loss in FY 2024)

Insufficient new directors

Third quarter 2025 earnings released: CA$0.003 loss per share (vs CA$0.002 loss in 3Q 2024)

New major risk - Negative shareholders equity

Ayurcann Holdings Corp., Annual General Meeting, Jun 23, 2025

Second quarter 2025 earnings released: CA$0.001 loss per share (vs CA$0.005 loss in 2Q 2024)

Insufficient new directors

Ayurcann Holdings Corp. Announces Chief Financial Officer Changes, Effective December 2, 2024

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Full year 2024 earnings released: CA$0.022 loss per share (vs CA$0.035 loss in FY 2023)

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) entered into a definitive business combination agreement to acquire Ayurcann Holdings Corp. (CNSX:AYUR).

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.007 loss in 3Q 2023)

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.001 loss in 2Q 2023)

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 1Q 2023)

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

Full year 2023 earnings released: CA$0.035 loss per share (vs CA$0.026 loss in FY 2022)

Ayurcann Holdings Corp. Provides Corporate Update

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.001 profit in 1Q 2022)

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

Full year 2022 earnings released: CA$0.026 loss per share (vs CA$0.003 loss in FY 2021)

Ayurcann Holdings Corp. Expands Product Offerings Across Canada

Ayurcann Holdings Corp. (CNSX:AYUR) completed the acquisition of Joints and Hustle & Shake Inc. from Tetra Oils Inc. for CAD 3.6 million.

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 3Q 2021)

High number of new and inexperienced directors

Ayurcann Holdings Corp. Receives Flower Sales Licence from Health Canada

Ayurcann Holdings Corp. (CNSX:AYUR) signed a letter of intent to acquire 100% interest in Joints and Hustle & Shake Inc. from Tetra Oils Inc.

Consensus forecasts updated

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in FY 2020)

Ayurcann Holdings Corp. announced that it has received CAD 0.602832 million in funding

Ayurcann Holdings Corp. announced that it expects to receive CAD 0.5 million in funding

Shareholder Returns

Price Volatility

About the Company

Ayurcann Holdings Corp. Fundamentals Summary

Earnings & Revenue

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources